Expasy logo

UniProtKB/Swiss-Prot variant pages

UniProtKB/Swiss-Prot Q99972: Variant p.Tyr437His

Myocilin
Gene: MYOC
Feedback?
Variant information Variant position: help 437 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Type of variant: help LP/P [Disclaimer] The variants are classified into three categories: LP/P, LB/B and US.
  • LP/P: likely pathogenic or pathogenic.
  • LB/B: likely benign or benign.
  • US: uncertain significance
Residue change: help From Tyrosine (Y) to Histidine (H) at position 437 (Y437H, p.Tyr437His). Indicates the amino acid change of the variant. The one-letter and three-letter codes for amino acids used in UniProtKB/Swiss-Prot are those adopted by the commission on Biochemical Nomenclature of the IUPAC-IUB.
Physico-chemical properties: help Change from large size and aromatic (Y) to medium size and polar (H) The physico-chemical property of the reference and variant residues and the change implicated.
BLOSUM score: help 2 The score within a Blosum matrix for the corresponding wild-type to variant amino acid change. The log-odds score measures the logarithm for the ratio of the likelihood of two amino acids appearing by chance. The Blosum62 substitution matrix is used. This substitution matrix contains scores for all possible exchanges of one amino acid with another:
  • Lowest score: -4 (low probability of substitution).
  • Highest score: 11 (high probability of substitution).
More information can be found on the following page
Variant description: help In GLC1A. Any additional useful information about the variant.
Other resources: help Links to websites of interest for the variant.


Sequence information Variant position: help 437 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Protein sequence length: help 504 The length of the canonical sequence.
Location on the sequence: help WETNIRKQSVANAFIICGTL Y TVSSYTSADATVNFAYDTGT The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.
Residue conservation: help The multiple alignment of the region surrounding the variant against various orthologous sequences. 
Human                         WETN------IRKQSVA---------NAFIICGTLYTVSSYTSADATVNFAYDTGT

                              WETN------IRKQSVA---------NAFVICGHLYTISSY

Mouse                         WETN------IRKQSVA---------NAFVICGILYTVSSY

Rat                           WETN------IRKQSVA---------NAFVICGILYTVSSY

Bovine                        WETN------IRKQSVA---------NAFIICGTLYTVSSY

Rabbit                        WETN------IRKQSVA---------NAFIICGTLYTVSSY

Cat                           WETN------IRKQSVA---------NAFIICGRLYTVSSY

Slime mold                    APTAPGGAPMMKKPAPAPGGAPMMKKPAPVPGGPAPGGSAI
Sequence annotation in neighborhood: help The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:
  • Type: the type of sequence feature.
  • Positions: endpoints of the sequence feature.
  • Description: contains additional information about the feature.
TypePositionsDescription
Chain 33 – 504 Myocilin
Chain 227 – 504 Myocilin, C-terminal fragment
Domain 244 – 503 Olfactomedin-like
Binding site 428 – 428
Binding site 429 – 429
Beta strand 435 – 440



Literature citations
Identification of a gene that causes primary open angle glaucoma.
Stone E.M.; Fingert J.H.; Alward W.L.M.; Nguyen T.D.; Polansky J.R.; Sunden S.L.F.; Nishimura D.; Clark A.F.; Nystuen A.; Nichols B.E.; Mackey D.A.; Ritch R.; Kalenak J.W.; Craven E.R.; Sheffield V.C.;
Science 275:668-670(1997)
Cited for: NUCLEOTIDE SEQUENCE [GENOMIC DNA / MRNA]; VARIANTS GLC1A VAL-364 AND HIS-437; Prevalence of mutations in TIGR/Myocilin in patients with adult and juvenile primary open-angle glaucoma.
Wiggs J.L.; Allingham R.R.; Vollrath D.; Jones K.H.; De La Paz M.; Kern J.; Patterson K.; Babb V.L.; Del Bono E.A.; Broomer B.W.; Pericak-Vance M.A.; Haines J.L.;
Am. J. Hum. Genet. 63:1549-1552(1998)
Cited for: VARIANTS GLC1A LYS-352; LEU-370; MET-377 AND HIS-437;
Disclaimer: Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. They are not in any way intended to be used as a substitute for professional medical advice, diagnostic, treatment or care.